JPMorgan Chase & Co. Has $992,000 Holdings in OrthoPediatrics Corp. (NASDAQ:KIDS)

JPMorgan Chase & Co. raised its holdings in OrthoPediatrics Corp. (NASDAQ:KIDS - Free Report) by 204.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 42,817 shares of the company's stock after acquiring an additional 28,768 shares during the period. JPMorgan Chase & Co. owned about 0.18% of OrthoPediatrics worth $992,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors also recently modified their holdings of KIDS. Rhumbline Advisers increased its stake in OrthoPediatrics by 4.1% during the 4th quarter. Rhumbline Advisers now owns 26,411 shares of the company's stock worth $612,000 after purchasing an additional 1,042 shares in the last quarter. R Squared Ltd bought a new stake in shares of OrthoPediatrics during the fourth quarter worth $48,000. Bank of New York Mellon Corp increased its position in shares of OrthoPediatrics by 3.8% during the fourth quarter. Bank of New York Mellon Corp now owns 57,710 shares of the company's stock worth $1,338,000 after acquiring an additional 2,099 shares in the last quarter. American Century Companies Inc. raised its holdings in shares of OrthoPediatrics by 13.2% during the fourth quarter. American Century Companies Inc. now owns 26,410 shares of the company's stock worth $612,000 after acquiring an additional 3,072 shares during the period. Finally, KLP Kapitalforvaltning AS bought a new stake in OrthoPediatrics in the 4th quarter valued at $79,000. 69.05% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several research firms have issued reports on KIDS. Stifel Nicolaus dropped their price target on OrthoPediatrics from $40.00 to $32.00 and set a "buy" rating on the stock in a research note on Wednesday, March 5th. Truist Financial dropped their target price on OrthoPediatrics from $26.00 to $24.00 and set a "hold" rating on the stock in a research report on Friday, April 11th. Lake Street Capital assumed coverage on OrthoPediatrics in a research note on Monday, April 7th. They issued a "buy" rating and a $37.00 target price on the stock. Finally, Needham & Company LLC reaffirmed a "buy" rating and set a $42.00 price target on shares of OrthoPediatrics in a research note on Wednesday, April 9th. One equities research analyst has rated the stock with a hold rating and four have issued a buy rating to the stock. Based on data from MarketBeat, OrthoPediatrics has an average rating of "Moderate Buy" and an average target price of $37.00.

Insider Transactions at OrthoPediatrics

In other news, General Counsel Daniel J. Gerritzen sold 5,310 shares of OrthoPediatrics stock in a transaction that occurred on Tuesday, March 18th. The stock was sold at an average price of $24.86, for a total transaction of $132,006.60. Following the completion of the transaction, the general counsel now directly owns 110,767 shares in the company, valued at approximately $2,753,667.62. The trade was a 4.57 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Gregory A. Odle sold 5,359 shares of the stock in a transaction on Tuesday, March 18th. The shares were sold at an average price of $24.86, for a total value of $133,224.74. Following the completion of the sale, the insider now owns 148,788 shares in the company, valued at approximately $3,698,869.68. This trade represents a 3.48 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 23,732 shares of company stock worth $589,978 in the last ninety days. Insiders own 31.80% of the company's stock.

OrthoPediatrics Stock Performance

Shares of NASDAQ KIDS opened at $21.54 on Monday. The stock has a market capitalization of $523.14 million, a PE ratio of -17.51 and a beta of 1.17. OrthoPediatrics Corp. has a 52 week low of $20.25 and a 52 week high of $35.99. The stock has a 50 day moving average price of $23.43 and a 200 day moving average price of $24.40. The company has a debt-to-equity ratio of 0.19, a quick ratio of 3.68 and a current ratio of 7.17.

OrthoPediatrics (NASDAQ:KIDS - Get Free Report) last released its earnings results on Tuesday, March 4th. The company reported ($0.29) earnings per share for the quarter, beating the consensus estimate of ($0.33) by $0.04. OrthoPediatrics had a negative net margin of 15.00% and a negative return on equity of 5.78%. The business had revenue of $52.67 million during the quarter, compared to analysts' expectations of $51.16 million. During the same period last year, the business earned ($0.23) earnings per share. Analysts predict that OrthoPediatrics Corp. will post -0.93 earnings per share for the current fiscal year.

OrthoPediatrics Profile

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.

Want to see what other hedge funds are holding KIDS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for OrthoPediatrics Corp. (NASDAQ:KIDS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.